What is the debt of Fuji Pharma Co this year?
Fuji Pharma Co has a debt level of 26,738 JPY this year.
In 2024, Fuji Pharma Co's total debt was 26,738 JPY, a 26.47% change from the 21,142 JPY total debt recorded in the previous year.
Fuji Pharma Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Analyzing Fuji Pharma Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Investors pay close attention to Fuji Pharma Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Shifts in Fuji Pharma Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Fuji Pharma Co has a debt level of 26,738 JPY this year.
The debt of Fuji Pharma Co has increased by 26.47% compared to the previous year increased.
High debt can pose a risk for investors of Fuji Pharma Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
Low debt means that Fuji Pharma Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.
An increase in debt of Fuji Pharma Co can adversely affect the financial condition of the company and result in a higher burden on its finances.
A reduction in debt of Fuji Pharma Co can strengthen the company's financial position and improve its ability to meet its financial obligations.
Some factors that can influence the debt of Fuji Pharma Co include investments, acquisitions, operating costs, and revenue development.
The debts of Fuji Pharma Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
To change the debt, Fuji Pharma Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
Over the past 12 months, Fuji Pharma Co paid a dividend of 37 JPY . This corresponds to a dividend yield of about 2.84 %. For the coming 12 months, Fuji Pharma Co is expected to pay a dividend of 38.86 JPY.
The current dividend yield of Fuji Pharma Co is 2.84 %.
Fuji Pharma Co pays a quarterly dividend. This is distributed in the months of April, October, April, October.
Fuji Pharma Co paid dividends every year for the past 17 years.
For the upcoming 12 months, dividends amounting to 38.86 JPY are expected. This corresponds to a dividend yield of 2.99 %.
Fuji Pharma Co is assigned to the 'Health' sector.
To receive the latest dividend of Fuji Pharma Co from 12/1/2024 amounting to 22.5 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
The last dividend was paid out on 12/1/2024.
In the year 2023, Fuji Pharma Co distributed 35 JPY as dividends.
The dividends of Fuji Pharma Co are distributed in JPY.
Our stock analysis for Fuji Pharma Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fuji Pharma Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.